Biotechnology News

April 7, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Presentations at the 2014 Annual Meeting of the American Association of Cancer Research

April 7, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals has started a collaboration with IsoTherapeutics Group of Houston to complete studies required for introduction of a new manufacturing process for Actimab-A.

April 7, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical To Relaunch Phase 2 Cutaneous T-Cell Lymphoma Study at Key Centers of Excellence

April 7, 2014

DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia Financing Release

April 7, 2014

LAWRENCE, Kan.--(BUSINESS WIRE)--Deciphera initiates Phase 1 clinical trial of its pan-RAF inhibitor LY3009120 (DP-4978), under development in collaboration with Eli Lilly. Data with preclinical activity presented at AACR.

April 7, 2014

LAWRENCE, Kan.--(BUSINESS WIRE)--Michael D. Taylor, Ph.D., appointed President and Chief Executive Officer of Deciphera as company is making clinical progress with its kinase inhibitor product candidates for several types of cancers

April 7, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Induction of Systemic Immunity Following Treatment of Tumors with PV-10 Reported By Moffitt Cancer Center Researchers

April 7, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has reached an agreement with Valeant to terminate the companies’ joint ventures in Canada, Mexico and Australia in the second quarter of 2014. In all three countries own Meda...

April 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT:SAN and NYSE:SNY), announced today that following constructive discussions with the U.S. Food and Drug Administration (FDA) the company plans to resubmit in the second quarter...

April 6, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced the presentation of early findings from studies exploring the relationship between tumor PD-L1 expression and clinical outcomes following monotherapy treatment with MK-3475.

April 6, 2014

CAMBRIDGE, Mass. & SAN DIEGO--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, announced that data from its lead, first-in-class program AG-221 will be...

April 6, 2014

DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST) announced today that it has introduced a highly specific PD-L1 rabbit monoclonal antibody (mAb), an important addition for researchers studying tumor immunology.

April 4, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) invites you to listen to David Pyott, Chairman of the Board and Chief Executive Officer, and Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial...

April 4, 2014

PARSIPPANY, N.J. & CHICAGO--(BUSINESS WIRE)--EXPAREL Use in Femoral Nerve Block for Total Knee Arthroplasty Further Supported by Additional Data from Phase 3 Pivotal Study, sNDA Submission Planned for Second Quarter 2014

April 4, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, April 24, 2014, after market close, the Company will...

April 4, 2014

WESTMINSTER, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has filed a universal shelf registration...

April 4, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that it expects to file its quarterly report on Form 10-Q for the 2nd quarter of fiscal year 2014 on Wednesday, April 9. A conference call will be held at 4:15 pm ET

April 4, 2014

BOSTON--(BUSINESS WIRE)--Attorneys in the Corporate & Securities and Life Sciences Practices of Mintz Levin, together with European counsel, recently represented QIAGEN N.V. in a major offering of convertible notes.

April 4, 2014

SAN DIEGO--(BUSINESS WIRE)--Cynvenio Biosystems will present data that sequence analysis of DNA recovered from circulating tumor cells outperforms cell free derived DNA template from the same patient sample at AACR in San Diego.

April 4, 2014

SALT LAKE CITY--(BUSINESS WIRE)--3M Health Information Systems calls passage of bill H.R. 4302 (SGR or "doc fix" bill), which delays ICD-10 implementation until October 2015, a vote for the past, not the future of healthcare.

April 4, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”)(STO:MEDAA) pursuant to the Securities Markets Act and/or the Financial Instruments Trading act. The...

April 4, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS) today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price of $12.75 per share to the public.

April 4, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc., (NASDAQ: OXBT) appoints Gerald Proehl, former President and CEO of Santarus, Inc. to company’s Board of Directors.

April 4, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck and Ferring today announced their collaboration with the WHO to advance a new, proprietary formulation of carbetocin that is designed to be stable at room temperature.

April 4, 2014

BERLIN--(BUSINESS WIRE)--NOXXON presents positive results from emapticap pegol phase IIa diabetic nephropathy study:anti-CCL2 /MCP-1 Spiegelmer NOX-E36 shows beneficial and lasting effects on albuminuria and glycemic control.

April 4, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces approval from the U.S. FDA for the Protégé (TM) upgradeable neurostimulator — the world’s smallest, longest-lasting rechargeable device to treat chronic pain.

April 4, 2014

INDIANAPOLIS--(BUSINESS WIRE)--YourEncore today announced that Timothy R. Franson, M.D., has been named Chief Medical Officer.

April 4, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services,...

April 4, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that Mitchell S. Steiner, its vice chairman and chief executive officer (CEO) and a co-founder of the company, is leaving GTx to pursue other business interests. Dr....

April 4, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced today that Dr. Marc Hellerstein, KineMed’s President and CSO, will give an invited presentation titled “...

April 4, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) today announced the pricing of its initial public offering of 65,000,000 shares of its common stock at an initial public offering price to the public of $20.00 per share,...

April 3, 2014

SAN DIEGO--(BUSINESS WIRE)--Reveal Biosciences (San Diego, CA), ACD Certified RNAscope® Service Provider, announces the availability of RNAscope® in situ hybridization (ISH) technology to researchers in the preclinical space.

April 3, 2014

BOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm investigates CytRx Corporation (Nasdaq: CYTR).

April 3, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., a leader in metabolomics-driven biomarker discovery, announced today the launch of DiscoveryHD4™, the company’s fourth-generation metabolomics platform. This new technology platform...

April 3, 2014

TENAFLY, N.J.--(BUSINESS WIRE)--SAFE-BioPharma DIGI Award Goes to European Medicines Agency, Astellas Pharma, DocuSign, Cegedim Relationship Management, Arxspan, World Pharmaceutical Frontiers Magazine

April 3, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014. Results of Phase III Clinical Trials of Eluxadoline to be Presented on May 6.

April 3, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its first quarter 2014 financial results on Thursday, April 17, 2014, at 7:30 a.m. Central Time. To access the call, please...

April 3, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in...

April 3, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) today announced that the One-on-One Partnering™ system is now open for the 2014 BIO International Convention®, taking place in San Diego from June 23-26.

April 3, 2014

LOS ANGELES--(BUSINESS WIRE)--Amy Purdy, who has already inspired millions with her medal-winning performance at the Paralympic snowboarding competition in Sochi last month, has opened yet another door for amputees and those with “disabilities”...

April 3, 2014

--(BUSINESS WIRE)--MdBio Foundation hosts ATLAS – a career symposium for high school juniors, seniors and college undergrads typically underrepresented in Science STEM fields.

April 3, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announces the...

April 3, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV), A clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease is pleased to update shareholders...

April 3, 2014

LONDON--(BUSINESS WIRE)--A delegation from one of the world’s leading universities, UCL (University College London) will be visiting Mexico from April 5th-12th to meet with some of the country’s top universities and organisations to discuss...

April 3, 2014

HEIDELBERG, Germany--(BUSINESS WIRE)--Novaliq GmbH today announced the commencement of a Phase 1 study for CyclASol (Cyclosporin solution) following US and European patent approval of the solution for the treatment of dry eye syndrome. While...